XML 12 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Non-voting Common Stock
Voting Common Stock
Common Stock
Common Stock
Non-voting Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balances at Dec. 31, 2024 $ 240,970     $ 5 $ 1 $ 616,009 $ 51 $ (375,096)
Balances, shares at Dec. 31, 2024       52,314,039 4,276,588      
Stock-based compensation expense 3,414         3,414    
Net loss (34,127)             (34,127)
Unrealized loss on available-for-sale securities (55)           (55)  
Balances at Mar. 31, 2025 210,202     $ 5 $ 1 619,423 (4) (409,223)
Balances, shares at Mar. 31, 2025       52,314,039 4,276,588      
Balances at Dec. 31, 2025 123,123     $ 5 $ 1 627,979 0 (504,862)
Balances, shares at Dec. 31, 2025   4,276,588 52,625,035 52,625,035 4,276,588      
Issuance of common stock under ESPP plan 0         (1)    
Issuance of common stock upon exercise of pre-funded warrants       $ 1        
Issuance of common stock upon exercise of pre-funded warrants, shares       3,199,687        
Stock-based compensation expense 2,465         2,465    
Net loss (28,666)             (28,666)
Unrealized loss on available-for-sale securities 0              
Balances at Mar. 31, 2026 $ 96,922     $ 6 $ 1 $ 630,443 $ 0 $ (533,528)
Balances, shares at Mar. 31, 2026   4,276,588 55,824,722 55,824,722 4,276,588